Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
暂无分享,去创建一个
E. Franek | Magdalena Walicka | G. Rydzewska | K. Lewandowski | M. Kaniewska | Martyna Więcek | Paulina Panufnik | E. Tulewicz-Marti | Paulina Szwarc | M. Więcek | P. Panufnik
[1] A. Zawada,et al. The associations between vitamin D, bone mineral density and the course of inflammatory bowel disease in Polish patients. , 2022, Polish archives of internal medicine.
[2] G. Rydzewska,et al. Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease , 2022, Journal of clinical medicine.
[3] J. Reguła,et al. Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology , 2021, Przeglad gastroenterologiczny.
[4] A. Rychter,et al. Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease , 2021, Nutrients.
[5] D. Mellström,et al. Physical exercise is associated with beneficial bone mineral density and body composition in young adults with childhood-onset inflammatory bowel disease , 2021, Scandinavian journal of gastroenterology.
[6] F. Bendtsen,et al. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease , 2020, World journal of gastroenterology.
[7] N. Watts,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[8] G. Scambia,et al. Role of vitamin K2 in bone metabolism: a point of view and a short reappraisal of the literature , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[9] C. Cooper,et al. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2019, Calcified Tissue International.
[10] A. Moss,et al. Vitamin D in inflammatory bowel disease: more than just a supplement , 2018, Current opinion in gastroenterology.
[11] G. Rogler,et al. Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study , 2017, Medicine.
[12] A. Lyra,et al. Risk factors for osteoporosis in inflammatory bowel disease patients. , 2015, World journal of gastrointestinal pathophysiology.
[13] N. Yurgin,et al. Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US , 2013, Applied Health Economics and Health Policy.
[14] E. Małecka-Panas,et al. Guidelines for the management of ulcerative colitis. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology , 2012 .
[15] J. Callejas-Rubio,et al. [Vitamin D deficiency and bone mineral density in Crohn's disease]. , 2011, Medicina clinica.
[16] G. Radford-Smith,et al. Body composition and muscle strength as predictors of bone mineral density in Crohn’s disease , 2009, Journal of Bone and Mineral Metabolism.
[17] M. Koršić,et al. Proinflammatory cytokines and receptor activator of nuclear factor κB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease , 2009, European journal of gastroenterology & hepatology.
[18] W. Leslie,et al. Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study , 2008, The American Journal of Gastroenterology.
[19] D. Armstrong,et al. Evaluation of densitometric bone-muscle relationships in Crohn's disease. , 2007, Bone.
[20] E. Vasiliauskas,et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density , 2004, Gut.
[21] J. Sanderson,et al. Bone density improves with disease remission in patients with inflammatory bowel disease , 2003, European journal of gastroenterology & hepatology.
[22] Peter Vestergaard,et al. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. , 2002, American journal of epidemiology.
[23] H. Bitter,et al. Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. , 2001, Scandinavian journal of gastroenterology.
[24] L. Schurgers,et al. Abnormal bone turnover in long‐standing Crohn’s disease in remission , 2001, Alimentary pharmacology & therapeutics.
[25] S. Laurberg,et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis , 2000, Gut.
[26] G. Porro,et al. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis , 2000, Journal of internal medicine.
[27] Z. Tulassay,et al. Altered Bone Metabolism in Inflammatory Bowel Disease , 1998, American Journal of Gastroenterology.
[28] J. Jahnsen,et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. , 1997, Gut.
[29] M. Manns,et al. Altered bone metabolism in inflammatory bowel disease. , 1997, The American journal of gastroenterology.
[30] F. Kaplan,et al. Prevention and management of osteoporosis. , 1995, Clinical symposia.
[31] B. Creamer,et al. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. , 1977, Gut.